MedPath

Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community

Not Applicable
Active, not recruiting
Conditions
HIV Infections
Opioid-use Disorder
Tuberculosis
Hepatitis B
Depression
Syphilis
Hepatitis C
Interventions
Behavioral: SBIRT
Registration Number
NCT04947475
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to evaluate the efficacy a Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for linking opioid dependent individuals currently incarcerated or in probation in Moldova, Kyrgyzstan, and Ukraine to opioid substitution therapy in the community after release or during their probation period.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
835
Inclusion Criteria
  1. 18 years of age or older

  2. Within 180 days of release or possible release (eligible for parole) to the community, but greater than 7 days to release to the community OR currently in probation.

  3. FOR THOSE IN PRISON: Relocating to a location within 30 km (approximately 60-minute commute) of the referred Narcology center. Each participant will be asked the address he/she is planning to reside under that will be immediately checked on the map to determine the travel time. A participant then will be asked if he/she would be willing to travel the distance to a particular OAT site. If a person does not meet this inclusion criterion, he/she will be referred to a local harm reduction center.

  4. Meets ICD-10 screening criteria for pre-incarceration opioid dependence

    FOR THOSE IN PROBATION:

  5. Living within 30 km of an OAT delivery site

  6. Not having received OAT in the last 15 days.

  7. Positive for OUD

Read More
Exclusion Criteria
  1. Pregnant or may become pregnant
  2. FOR THOSE IN PRISON: Will be released from prison in 7 days or less.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Screening, Brief Intervention, & Referral to Treatment (SBIRT) ProgramSBIRTThere are two objectives to the Brief Intervention. First, the BI is designed to inform potential participants on the risks of substance misuse, abuse, and dependency by illustrating the potential hazards and adverse health consequences. Second, the BI aims to motivate potential participants to reduce risky behavior (e.g., continued drug use) and seek treatment for their substance dependence disorder.
Primary Outcome Measures
NameTimeMethod
Enrollment on OAT12 months

Total number of participants who enroll on OAT divided by the number of participants who underwent study procedures, per country.

Secondary Outcome Measures
NameTimeMethod
OAT Importance6 months

Overall mean change in composite score of importance of initiating OAT pre vs post intervention stratified by study groups (enrolled vs not en rolled on OAT) at the 6-month mark.

OAT Knowledge6 month

Overall mean change in composite score of knowledge of OAT pre vs post intervention stratified by study groups (enrolled vs not en rolled on OAT) at the 6-month mark.

OAT Attitudes6 months

Overall mean change in composite score of attitudes towards OAT pre vs post intervention stratified by study groups (enrolled vs not en rolled on OAT) at the 6-month mark.

Interest in OAT6 months

Overall mean change in composite score of interest in initiating OAT pre vs post intervention stratified by study groups (enrolled vs not en rolled on OAT) at the 6-month mark.

OAT Difficulty6 months

Overall mean change in composite score of difficulty in initiating OAT pre vs post intervention stratified by study groups (enrolled vs not en rolled on OAT) at the 6-month mark.

Trial Locations

Locations (3)

AIDS Foundation East-West

πŸ‡°πŸ‡¬

Bishkek, Kyrgyzstan

AFI - Act for Involvement

πŸ‡²πŸ‡©

Chisinau, Moldova, Republic of

Ukrainian Institute for Public Health Policy

πŸ‡ΊπŸ‡¦

Kyiv, Ukraine

Β© Copyright 2025. All Rights Reserved by MedPath